Mylan Launches World’s First Trastuzumab Biosimilar in India

American drug pharmaceutical firm Mylan announced the launch of its breast cancer drug through its Indian subsidiary in the country.

The drug is the world’s first trastuzumab biosimilar and will be marketed under the brand name Hertraz Herceptin.

Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.

The drug, approved by the Drug Controller General of India, will available in two strengths, 440mg and 150mg, and will be used in treating patients suffering from HER2- positive metastatic breast cancer.

“Mylan is excited to offer Hertraz to the thousands of women in India suffering from metastatic breast cancer who are in need of a high quality, more affordable treatment option. The launch of Hertraz not only represents a significant milestone in our biosimilars development program with Biocon, but more importantly, supports our mission to expand access to high quality medicine around the world and demonstrates our progress against one of Mylan’s key future growth drivers”, Mylan CEO Heather Bresch said.

Breast Cancer - Causes, Risks, Symptoms, Diagnosis, Staging, Treatment, Prevention & Prognosis
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle changes help in controlling breast cancer.

Source-Medindia

Recent Advances and the Present Status of Breast cancer Management
The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.

Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.